Teva Pharmaceutical Q4 2024 Earnings Preview

  • Teva Pharmaceutical (NYSE:TEVA) is scheduled to announce Q4 earnings results on Wednesday, January 29th, before market open.
  • The consensus EPS Estimate is $0.70 (-30.0% Y/Y) and the consensus Revenue Estimate is $4.12B (-7.6% Y/Y).
  • Over the last 2 years, TEVA

Leave a Reply

Your email address will not be published. Required fields are marked *